933782-03-7 ((2-bromo-4-methylthiazol-5-yl)methanol,(2-bromo-4-methyl-1,3-thiazol-5-yl)methanol)

CAS号:
933782-03-7
中文名称:
(2-bromo-4-methylthiazol-5-yl)methanol
英文名称:
(2-bromo-4-methyl-1,3-thiazol-5-yl)methanol
分子式:
C5H6BrNOS
分子量:
208.076239109039

(2-bromo-4-methylthiazol-5-yl)methanol(933782-03-7)名称与标识符

名称

中文别名:
(2-溴-4-甲基噻唑-5-基)甲醇;
英文别名:
(2-bromo-4-methylthiazol-5-yl)methanol;XLVPVZKGRKXLIA-UHFFFAOYSA-N;5-Thiazolemethanol, 2-bromo-4-methyl-;(2-Bromo-4-methyl-thiazol-5-yl)-methanol;(2-Bromo-4-methylthiazol-5-yl)methanol, AldrichCPR;2-Bromo-4-methyl-5-thiazolemethanol (ACI);(2-Bromo-4-methyl-1,3-thiazol-5-yl)methanol;DB-309704;CS-0162332;933782-03-7;E76577;BS-50892;EN300-3253291;SCHEMBL2244526;

标识符

MDL:
MFCD20441256
InChIKey:
XLVPVZKGRKXLIA-UHFFFAOYSA-N
Inchi:
1S/C5H6BrNOS/c1-3-4(2-8)9-5(6)7-3/h8H,2H2,1H3
SMILES:
BrC1=NC(C)=C(CO)S1

(2-bromo-4-methylthiazol-5-yl)methanol(933782-03-7)物化性质

计算特性

  • 精确分子量 : 206.93535g/mol
  • 氢键供体数量 : 1
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 1
  • 同位素质量 : 206.93535g/mol
  • 重原子数量 : 9
  • 复杂度 : 103
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.5
  • 拓扑分子极性表面积 : 61.4

(2-bromo-4-methylthiazol-5-yl)methanol(933782-03-7)推荐厂家 更多厂家(9)

(2-bromo-4-methylthiazol-5-yl)methanol(933782-03-7)合成路线

合成路线:1 步
反应条件:
参考文献:
Parallel Chemistry Approach to Identify Novel Nuclear Receptor Ligands Based on the GW0742 Scaffold
Teske, Kelly A.; Rai, Ganesha; Nandhikonda, Premchendar; Sidhu, Preetpal S.; Feleke, Belaynesh; et al, ACS Combinatorial Science, 2017, 19(10), 646-656
合成路线:1 步
反应条件:
参考文献:
Preparation of heterocyclic derivatives such as 2-aminopyridine and 3-aminopyridazine derivatives as anaplastic lymphoma kinase (ALK) inhibitors for the treatment of diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Novel oxazole and thiazole compounds as β-catenin modulators and uses thereof
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of preparing the same, and pharmaceutical composition comprising the same
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of isoxazole derivatives as GPR40 modulators
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Phenyl-1,2,4-oxadiazolone derivatives as PPAR agonists, processes for their preparation and their use as pharmaceuticals
, World Intellectual Property Organization, , ,